These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 13893049)

  • 1. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of Clostridium botulinum toxoid. II. Type B toxoid.
    VOROB'EV AA; VASIL'EV NN; ENICHEV VM; PATRIKEYEV GT; SHEVELEV VM; ZYBIN VD; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1851-6. PubMed ID: 14040098
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE EFFECT OF PRELIMINARY ADMINISTRATION OF TOXOID ON THE RESISTANCE OF MICE TO BOTULINUM TOXIN. (PRELIMINARY REPORT)].
    ZHUK LN
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jul; 41():39-42. PubMed ID: 14247222
    [No Abstract]   [Full Text] [Related]  

  • 5. [STUDY OF BOTULINUM TOXOIDS. VI. TYPE D BOTULINUM TOXOID].
    VOROBEV AA; VASILEV NN; SHEVELEV VM; VORONOVA ZA; PETROVA EK; BAZHENOVA GA; ANDROSHCHUK SM
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Sep; 40():87-92. PubMed ID: 14119975
    [No Abstract]   [Full Text] [Related]  

  • 6. The partial reactivation of formalin-inactivated Clostridium botulinum type C toxin.
    MARTY EW
    Am J Vet Res; 1961 Jul; 22():770-4. PubMed ID: 13767602
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on immunity to toxins of Clostridium botulinum. V. Detoxification of purified type A and type B toxins, and the antigenicity of univalent and bivalent aluminium phosphate adsorbed toxoids.
    WRIGHT GG; DUFF JT; FIOCK MA; DEVLIN HB; SODERSTROM RL
    J Immunol; 1960 Apr; 84():384-9. PubMed ID: 13846070
    [No Abstract]   [Full Text] [Related]  

  • 8. [Research in vitro on toxigenesis of Cl. tetani and Cl. botulinum].
    D'ARCA SIMONETTI A
    Nuovi Ann Ig Microbiol; 1959; 10():342-58. PubMed ID: 13813594
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of Clostridium botulinum toxoids. I. Type A Clostridium botulinum toxoid.
    VOROB'EV AA; VASIL'EV NN; PATRIKEYEV GT; ZYBIN VD; SHMELEV VM; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1601-8. PubMed ID: 14040099
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on immunity to toxins of Clostridium botulinum. VII. Purification and detoxification of trypsin-activated type E toxin.
    FIOCK MA; YARINSKY A; DUFF JT
    J Bacteriol; 1961 Jul; 82(1):66-71. PubMed ID: 13699727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of the kinetics of detoxication of purified type A botulinum toxin by formalin].
    VASIL'EV NN
    Biokhimiia; 1961; 26():667-72. PubMed ID: 13780379
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON IMMUNITY TO TOXINS OF CLOSTRIDIUM BOTULINUM. IX. IMMUNOLOGIC RESPONSE OF MAN TO PURIFIED PENTAVALENT ABCDE BOTULINUM TOXIOD.
    FIOCK MA; CARDELLA MA; GEARINGER NF
    J Immunol; 1963 May; 90():697-702. PubMed ID: 14054890
    [No Abstract]   [Full Text] [Related]  

  • 13. Phagocytosis of staphylococci by mouse leukocytes in the presence of botulinum toxin.
    FREEMAN NL
    J Bacteriol; 1961 Jan; 81(1):156-7. PubMed ID: 13701643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the amount of sorbent on the immunogenic property of botulin anatoxins].
    LABINSKII AP
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Feb; 33():78-84. PubMed ID: 14461267
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenicity of Clostridium botulinum type-E formol toxoid.
    Kondo H; Kondo S; Murata R; Sakaguchi G
    Jpn J Med Sci Biol; 1969 Apr; 22(2):75-85. PubMed ID: 4899485
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on immunity to toxins of Clostridium botulinum. IV. Production and purification of type C toxin for conversion to toxoid.
    CARDELLA MA; DUFF JT; GOTTFRIED C; BEGEL JS
    J Bacteriol; 1958 Mar; 75(3):360-5. PubMed ID: 13513612
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on immunity to toxins of Clostridium botulinum. II. Production and purification of type B toxin for toxoid.
    DUFF JT; KLERER J; BIBLER RH; MOORE DE; GOTTFRIED C; WRIGHT GG
    J Bacteriol; 1957 May; 73(5):597-601. PubMed ID: 13428702
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological difference between the toxin of a progeolytic strain and that of a nonproteolytic strain of Clostridium botulinum type B.
    Shimizu T; Kondo H
    Jpn J Med Sci Biol; 1973 Dec; 26(5):269-71. PubMed ID: 4601358
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinal toxin and toxoid as antigens.
    Heimach RC; Champion LA; Sugiyama H
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):151-4. PubMed ID: 4920940
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.